Caldwell M. Bridges

Caldwell M. Bridges

Auto-generated profile, based on publicly available information

Caldwell M. Bridges

Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
LDLauren J. Donovan
Lauren J. Donovan
CBCaldwell M. Bridges
Caldwell M. Bridges
ANAmy R. Nippert
Amy R. Nippert
MWMeng Wang
Meng Wang
SWShaogen Wu
Shaogen Wu
VTVivianne L. Tawfik
Vivianne L. Tawfik
Summary: Microglia contribute to the initiation of pain, however, a translationally viable approach addressing how or when to modulate these cells remains elusive. We used a targeted, inducible, genetic microglial depletion strategy at both acute and acute-to-chronic transition phases in the clinically-relevant tibial fracture/casting pain model to determine the contribution of microglia to the initiation and maintenance of pain. We observed complete resolution of pain after transient microglial depletion at the acute-to-chronic phase, which coincided with the timeframe of full repopulation of microglia. These repopulated microglia were morphologically distinct from control microglia, signifying they may exhibit a unique transcriptome. RNA sequencing of repopulated spinal cord microglia identified genes of interest using weighted gene co-expression network analysis (WGCNA). We intersected these genes with a newly-generated single nuclei microglial dataset from human spinal cord dorsal horn and identified human-relevant genes that may ultimately promote pain resolution after injury. This work presents a novel approach to gene discovery in pain and provides comprehensive datasets for the development of future microglial-targeted therapeutics.